US FDA working to issue Moderna Covid vaccine approval

US FDA chief says 'rapidly' working to issue Moderna Covid-19 vaccine authorisation

The FDA is expected to grant the EUA as early as late Thursday or Friday

The US FDA informed Moderna Inc that it will rapidly work towards the finalisation and issuance of vaccine. Credit: AFP Photo

The US Food and Drug Administration (FDA) informed Moderna Inc that it will rapidly work towards the finalisation and issuance of emergency use authorisation (EUA) for its Covid-19 vaccine candidate, commissioner Stephen Hahn said late Thursday.

Also read: US FDA panel endorses Moderna’s Covid-19 vaccine

Earlier in the day, a panel of external advisers to the FDA overwhelmingly endorsed emergency use of Moderna vaccine candidate, virtually assuring a second option for protecting against Covid-19 for a pandemic-ravaged nation.

Coronavirus vaccine news live updates on DH

The FDA is expected to grant the EUA as early as late Thursday or Friday, providing another ray of hope to a nation that has lost more than 300,000 lives to Covid-19 and as record numbers of patients threaten to overwhelm US hospitals and healthcare workers.